Interviews



Interview with Professor Salim Abdool-Karim discussing the benefits of Truvada's use as a pre exposure prophylactic, post the FDA’s announcement to approval the drug as PrEP.

We use cookies to make your experience with us better. By continuing to use our website, you are agreeing to our use of cookies. To find out more see our privacy policy.

Close